Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > Gunner who do you think the judge will believe
View:
Post by edrose on Oct 20, 2022 4:25pm

Gunner who do you think the judge will believe

Prometics scientists with great reputations or the people who got rid of them and replaced them with their scientist who all of a sudden state results presented to retail investors in 2017,2018,2019 by prometics scientists and pierre laurin that where very good now are no longer good and they stopped research and sold plasma division like ryplasim molecule for peanuts just before fda approval

since takeover wiping out retail investors what as management done to improve shareholders value and what did the accomplish re research 

they did pay themselves big salaries and paid back the loans 
retail investors never got anything
Comment by GunnerG on Nov 07, 2022 4:23pm
Scientists have great reputations, agree.  The judge will only believe what is factual.  If scientists say they had an idea and was yet to be proven following FDA testing guidelines; well if they haven't proven it, it is nothing factual. You forget that Pierre and the so called top scientist, forget his name, were paid big bucks for decades.  Liminal apparently did further work ...more  
Comment by 37minus4 on Nov 08, 2022 7:47am
Gunner is a total c-hole but has a point about this mythical trial thing. Getting screwed by big time greedsters playing their game using their rules doesn't get trumped by a scientist saying they had a dynamite pipeline. So, the trial is scheduled to start when? Or is that another secret of Dunton Rainville? ;-) 33
Comment by stockbuphoon on Nov 11, 2022 3:57pm
it's fairly amazing that they had 5 indications where they said that they had great results in fibrosis and then had absolutely nothing at all!! They bet the entire company on 4050 and were spending $100M a year and not even doing trials! How is that even possible looking back? Why would a 70 year old well respected technical doctor scar his reputation by lying about all of these results ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities